DK399389D0 - Injicerbare oploesninger - Google Patents

Injicerbare oploesninger

Info

Publication number
DK399389D0
DK399389D0 DK399389A DK399389A DK399389D0 DK 399389 D0 DK399389 D0 DK 399389D0 DK 399389 A DK399389 A DK 399389A DK 399389 A DK399389 A DK 399389A DK 399389 D0 DK399389 D0 DK 399389D0
Authority
DK
Denmark
Prior art keywords
compound
dissolving
injectable solutions
group
fluorinated
Prior art date
Application number
DK399389A
Other languages
English (en)
Other versions
DK399389A (da
Inventor
Yasushi Mikura
Akihiro Nagai
Hisayoshi Shimizu
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK399389D0 publication Critical patent/DK399389D0/da
Publication of DK399389A publication Critical patent/DK399389A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK399389A 1988-08-18 1989-08-14 Injicerbare oploesninger DK399389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20510088 1988-08-18

Publications (2)

Publication Number Publication Date
DK399389D0 true DK399389D0 (da) 1989-08-14
DK399389A DK399389A (da) 1990-02-19

Family

ID=16501418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK399389A DK399389A (da) 1988-08-18 1989-08-14 Injicerbare oploesninger

Country Status (9)

Country Link
EP (1) EP0356143B1 (da)
KR (1) KR900002774A (da)
AT (1) ATE99935T1 (da)
CA (1) CA1333775C (da)
DE (1) DE68912238T2 (da)
DK (1) DK399389A (da)
ES (1) ES2062015T3 (da)
HU (1) HU204434B (da)
PT (1) PT91490B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652751B1 (en) * 1992-07-28 1996-10-23 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
TW280770B (da) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
EP0919231A1 (en) * 1997-10-15 1999-06-02 Biogenesis, S.A. Injectable parasiticide composition and process for the preparation
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
WO2002013789A1 (en) * 2000-08-15 2002-02-21 H. Lundbeck A/S Pharmaceutical composition containing 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl] -1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]
CA2419067C (en) 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
JP4020076B2 (ja) 2001-09-18 2007-12-12 ゼリア新薬工業株式会社 ベンズイミダゾール誘導体
KR100467100B1 (ko) * 2002-03-20 2005-01-24 일양약품주식회사 2-[(4-메톡시-3-메틸)-2-피리디닐]메틸설피닐-5-(1Ｈ-피롤-1-릴)-1Ｈ-벤즈이미다졸 또는 이의 Ｎа염을 함유하는주사제의 제조방법
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
CN101129368B (zh) * 2007-08-23 2012-10-10 常州市第四制药厂有限公司 含有兰索拉唑的冻干粉针
CN112353766A (zh) * 2020-10-27 2021-02-12 马鞍山丰原制药有限公司 一种兰索拉唑冻干制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (da) * 1968-10-21 1971-06-03
FR2542982B1 (fr) * 1983-03-23 1985-06-28 Vestra Union Sa Machine semi-automatique pour l'alignement des dessins des rabats de poches sur un devant de veston, et l'empilage automatique des pieces positionnees
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production

Also Published As

Publication number Publication date
HUT52956A (en) 1990-09-28
PT91490B (pt) 1995-05-04
ATE99935T1 (de) 1994-01-15
EP0356143A1 (en) 1990-02-28
HU204434B (en) 1992-01-28
EP0356143B1 (en) 1994-01-12
DK399389A (da) 1990-02-19
PT91490A (pt) 1990-03-08
ES2062015T3 (es) 1994-12-16
CA1333775C (en) 1995-01-03
DE68912238D1 (de) 1994-02-24
KR900002774A (ko) 1990-03-23
DE68912238T2 (de) 1994-07-14

Similar Documents

Publication Publication Date Title
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
ES2062015T3 (es) Soluciones inyectables.
AR245718A1 (es) Procedimiento para preparar un compuesto de imidazo (4,5-b)-piridina
KR960010635A (ko) 약제학적 화합물
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
EA199900935A1 (ru) Соединения индазоламида в качестве серотонинергических агентов
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
ES2064856T3 (es) Composiciones farmaceuticas que contienen compuestos triciclicos.
DE3879258D1 (de) Praeparat gegen ulcus.
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
JPS57136567A (en) N-2-hydroxy-3-substituted piperidine compound
JPS646261A (en) 4-thioquinazoline derivative, its production and antiulcer agent containing said derivative as active component
JPS6440467A (en) Novel substituted diphenylimidazole derivative
FI842112A0 (fi) Foerfarande foer framstaellning av- karbolin-3-karboxylsyraderivat.
SE7903200L (sv) Farmaceutiskt, serskilt diuretiskt verksamt preparat for parenteral administration
GB2104515B (en) Sulphimines
KR840009102A (ko) 치환된 이소퀴놀린 유도체의 제조방법
JPS5764683A (en) 2-(substituted phenyl)-5-alkylthiazolidin-4-one and remedy for pepticulcer containing said compound as active component
KR880006177A (ko) 구아니디노 메틸벤조산 유도체
JPS5414956A (en) Novel 3-amino-4-homoisotwistan derivative
JPS5754177A (ja) Chikanchiazoorujudotai
ATE18554T1 (de) Optisch aktive imidazolylpropanol-verbindungen und deren herstellung und anwendung.
KR870001181A (ko) 시클로펜탄 유도체의 제조방법
ATE79876T1 (de) Thioverbindungen.
FI921475A0 (fi) 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment